Yellow Fever 2.pptx
Transcript of Yellow Fever 2.pptx
-
7/25/2019 Yellow Fever 2.pptx
1/24
Diseases Carried by Insects
-
7/25/2019 Yellow Fever 2.pptx
2/24
Communicable Period
The time during which an infectious agent
may be transferred directly or indirectly
from an infected person to anotherperson, from an infected animal to
humans, or from an infected person to
animals, including arthropods
-
7/25/2019 Yellow Fever 2.pptx
3/24
Communicable Period
The time during which the patient is
infectious to others
-
7/25/2019 Yellow Fever 2.pptx
4/24
Incubation Period
The time interval between initial contact
with an infectious agent and the first
appearance of symptoms associated with
the infection.
-
7/25/2019 Yellow Fever 2.pptx
5/24
Incubation Period
In a vector, it is the time between entrance
of an organism into the vector and the
time when that vector can transmit the
infection (extrinsic incubation period.
-
7/25/2019 Yellow Fever 2.pptx
6/24
!uarantine
"eparating and restricting the movement
of well persons who may have been
exposed to a communicable disease to
see if they become ill
-
7/25/2019 Yellow Fever 2.pptx
7/24
Isolation
"eparation of ill persons who have a
communicable disease from those who
are healthy
-
7/25/2019 Yellow Fever 2.pptx
8/24
#$%%&' $)$*
-
7/25/2019 Yellow Fever 2.pptx
9/24
Introduction
#ellow fever is a viral disease, found in
tropical regions of +frica and the +mericas
It principally affects humans and
moneys, and is transmitted via the bite of
Aedesmos-uitoes
-
7/25/2019 Yellow Fever 2.pptx
10/24
Introduction
There are //,/// estimated cases of
yellow fever (with 0/,/// deaths per year
-
7/25/2019 Yellow Fever 2.pptx
11/24
Incubation Period
Three to six days
-
7/25/2019 Yellow Fever 2.pptx
12/24
1&T
The virus is carried from one animal to
another (hori2ontal transmission by a
biting mos-uito (the vector. The mos-uito
can also pass the virus via infected eggs
to its offspring (vertical transmission
There are three types of transmission
cycle3 Sylvatic, Intermediate, Urban
-
7/25/2019 Yellow Fever 2.pptx
13/24
-
7/25/2019 Yellow Fever 2.pptx
14/24
"ylvatic #ellow ever
Sylvatic(or 4ungle yellow fever occurs intropical rainforests
"ylvatic 1os-uitoes moneys
virus onto other mos-uitoes that feed onthem infect humans entering theforest
This produces sporadic cases, thema4ority of which are often young menworing in the forest e.g. logging
-
7/25/2019 Yellow Fever 2.pptx
15/24
Intermediate Cycle &f #ellow ever
"mall5scale epidemics in rural villages
Increased contact between man and
infected mos-uito leads to disease
This is the most common type of outbrea
seen in recent decades in +frica
-
7/25/2019 Yellow Fever 2.pptx
16/24
6rban #ellow ever
*esults in large explosive epidemics when
travelers from rural areas introduce the
virus into areas with high humanpopulation density. Domestic mos-uitoes,
most notably Aedes Aegypti, carry the
virus from person to person.
-
7/25/2019 Yellow Fever 2.pptx
17/24
-
7/25/2019 Yellow Fever 2.pptx
18/24
"igns 7 "ymptoms
+cute Phase3
ever
1uscle pain (with prominent bacache
8eadache
"hivers
%oss of appetite
9ausea and:or vomiting
+fter three to four days most patientsimprove and their symptoms disappear
-
7/25/2019 Yellow Fever 2.pptx
19/24
"igns 7 "ymptoms
;toxic phase> within ? hours
ever reappear
@aundice and complains of abdominalpain with vomiting
Aleeding can occur from the mouth, nose,
eyes and:or stomach
-
7/25/2019 Yellow Fever 2.pptx
20/24
"igns 7 "ymptoms
Alood appears in the vomit and faeces.
Bidney failure
8alf of the patients in the >toxic phase> die
within ;/5;? days. The remainder recover
without significant organ damage
-
7/25/2019 Yellow Fever 2.pptx
21/24
Prevention
+dministering yellow fever vaccineas
part of routine infant immuni2ation
Preventing outbreas in high5ris areasthrough mass >catch5up> campaigns
Control of Aedes aegypti in urban
centres
-
7/25/2019 Yellow Fever 2.pptx
22/24
Prevention
#ellow fever vaccine is safe and highly
effective. The protective effect (immunity
occurs within one wee in
-
7/25/2019 Yellow Fever 2.pptx
23/24
Type of vaccine
No. of dosesSchedule
Booster
Contraindications
Adversereactions
Special
precautions
Live viral
One dose of 0.5 ml subcutaneouslyoutine immuni!ation "ith measles vaccine at nine
months of a#e
$nternational health re#ulations re%uire a booster
every &0 years
'## aller#y( immune deficiency from medication or
disease( symptomatic )$* infection(hypersensitivity to previous dose( pre#nancy+
)ypersensitivity to e##( rarely, encephalitis in the
very youn#( hepatic failure. are reports of deathfrom massive or#an failure -see above.
/o not #ive before si months of a#e( avoid durin#
pre#nancy
-
7/25/2019 Yellow Fever 2.pptx
24/24
*eceptive +rea3 an area in which yellow
fever does not exist but where conditions
would permit its development if introduced
+edes +egypti Index3 the percentage ofhouses and their premises in a limited well
defined area showing actual breeding of
aedes aegypti larvae